It’s time to fix the staggering global inequities in access to COVID-19 vaccines, writes Gavin Yamey in a

It’s not only sick patients who help researchers understand diseases.  In the 1990s, a rare genetic mutation in 1 man who seemed impervious to HIV proved key to creating antiretrovirals against the disease, opening up “a whole new realm of medical science.”  

Good news on reinfection front: US NIH researchers found that people with SARS-CoV-2 antibodies showed “substantial” immunity to the virus at least for a few months, 

Superspreader events have long been recognized as a key player in this pandemic.  

Behind each COVID-19 death is an unfathomable ordeal that is largely witnessed only by physicians and nurses.   The struggle for air is like breathing through a very narrow straw… indefinitely. Lungs feel “full of bees.”

Children—who have largely been spared from the worst effects of COVID-19—are at the back of the vaccine line,

Responding to the rise of variants, the US FDA has issued new guidance for pharmaceutical companies on adapting COVID-19 

Latin American governments are accusing Pfizer of “bullying” in COVID-19 vaccine negotiations—saying it is insisting upon extreme guarantees against future legal cases like using embassies and military bases as collateral.   Protections for vaccine manufacturers in case of…

The unimaginable becomes real.  

For months, Africa’s intelligence and law enforcement circles have worried that counterfeit COVID-19 vaccines might flow through the continent’s free-trade ports, which are key economic drivers but also hubs for illicit imports, according to a deep-dive